Hospital praised for Hepatitis C work

Presentation of Certificate of Excellence Credit: Torrecárdenas University Hospital

The Torrecárdenas University Hospital in Almeria City is the first hospital in Spain to be formally recognised for its research into Hepatitis C.

Certificate of Excellence

A special Certificate of Excellence was presented to Manuel Vida Managing Director of the Hospital on May 19 by the President of the Spanish Association for the Study of the Liver (AEHH), Dr. Manuel Romero, thanks to the hospital’s work being undertaken to try to eliminate Hepatitis C.

The document explaining the procedure for dealing with this viral infection is also endorsed by the Spanish Society of Digestive Pathology (SEPD), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Viral Hepatitis Study Group (GEHEP).

One of the most successful hepatitis C screening projects carried out by the Torrecárdenas University Hospital is screening in the Accident and Emergency Department, a project that began in 2021, which has allowed more than 18,000 patients to be screened and to diagnose more than 70 with having the infection enabling their treatment and cure.

Thank you for taking the time to read this article. Do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.

Written by

John Smith

Married to Ophelia in Gibraltar in 1978, John has spent much of his life travelling on security print and minting business and visited every continent except Antarctica. Having retired several years ago, the couple moved to their house in Estepona and John became a regular news writer for the EWN Media Group taking particular interest in Finance, Gibraltar and Costa del Sol Social Scene. Currently he is acting as Editorial Consultant for the paper helping to shape its future development. Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments